Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) has expanded its Australian Medical Advisory Board with the appointment of Associate Professor Dion Stub MBBS, PhD, FRACP of the Alfred Hospital and Monash University.
Associate Professor Stub specialises in structural heart procedures, including angioplasty, aortic valve replacement (TAVI) and balloon valvuloplasty.
He has further special interests in treating myocardial infarction and cardiac arrest, particularly with interventional methods.
“Welcome addition”
Anteris said that Associate Professor Stub's Medical Advisory Board participation was a welcome addition as it continued building clinical validation for its novel DurAVR™ 3D single-piece transcatheter aortic heart valve system.
Based in Melbourne, Associate Professor Stub is a highly experienced interventional cardiologist, having performed thousands of cardiac procedures, helping patients experience life to the fullest again.
“We are very pleased Associate Professor Stub is joining our Australian Medical Advisory Board," Anteris CEO Wayne Paterson said.
"His significant TAVI experience and ongoing contributions will greatly enhance our commercialisation and market development efforts in Australia.”